Filing Details

Accession Number:
0001179110-20-003590
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-03-12 19:01:27
Reporting Period:
2020-03-10
Accepted Time:
2020-03-12 19:01:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1292519 Invivo Therapeutics Holdings Corp. NVIV () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1271244 Richard Christopher C/O Invivo Therapeutics Holdings Corp.
One Kendall Square, Suite B14402
Cambridge MA 02139
Cfo And Treasurer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-03-10 3,636 $0.00 5,220 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrant (right to buy) Acquisiton 2020-03-10 3,636 $0.00 3,636 $2.75
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
3,636 2020-03-10 2025-03-10 No 4 P Direct
Footnotes
  1. The reported securities were sold together at a combined purchase price of $2.75 per share of common stock and warrant to purchase one share of common stock.